HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:391
|
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
  • [21] HUMAN ATRIAL-NATRIURETIC-FACTOR IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - PLASMA-LEVELS, HEMODYNAMIC, HORMONAL AND RENAL CHANGES AFTER INTRAVENOUS ADMINISTRATION
    RIEGGER, AJG
    KROMER, EP
    KOCKSIEK, K
    ACTA ENDOCRINOLOGICA, 1986, 111 : 166 - 166
  • [22] HEMODYNAMIC AND RENAL EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE IN CONGESTIVE HEART-FAILURE
    FIFER, MA
    MOLINA, CR
    QUIROZ, AC
    GILES, TD
    HERRMANN, HC
    DESCHEERDER, IR
    CLEMENT, DL
    KUBO, S
    CODY, RJ
    COHN, JN
    FOWLER, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03): : 211 - 216
  • [23] HEMODYNAMIC AND RENAL EFFECTS OF URODILATIN BOLUS INJECTIONS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    KENTSCH, M
    LUDWIG, D
    DRUMMER, C
    GERZER, R
    MULLERESCH, G
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (10) : 662 - 669
  • [24] Sympathetic responses to atrial natriuretic peptide in patients with congestive heart failure
    Azevedo, ER
    Newton, GE
    Parker, AB
    Floras, JS
    Parker, JD
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (01) : 129 - 135
  • [25] ATTENUATED RENAL EXCRETORY RESPONSE TO ATRIAL-NATRIURETIC-PEPTIDE IN CONGESTIVE-HEART-FAILURE IN MAN
    EISKJAER, H
    BAGGER, JP
    DANIELSEN, H
    JENSEN, JD
    JESPERSEN, B
    THOMSEN, K
    PEDERSEN, EB
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1991, 33 (01) : 61 - 74
  • [26] HORMONAL, GLOBAL, AND REGIONAL HEMODYNAMIC-RESPONSES TO A VASCULAR ANTAGONIST OF VASOPRESSIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE WITH AND WITHOUT HYPONATREMIA
    NICOD, P
    BIOLLAZ, J
    WAEBER, B
    GOY, JJ
    POLIKAR, R
    SCHLAPFER, J
    SCHALLER, MD
    TURINI, GA
    NUSSBERGER, J
    HOFBAUER, KG
    BRUNNER, HR
    BRITISH HEART JOURNAL, 1986, 56 (05): : 433 - 439
  • [27] NATURE OF ATRIAL-NATRIURETIC-PEPTIDE IN PLASMA FROM PATIENTS WITH CONGESTIVE-HEART-FAILURE
    YAMAJI, T
    ISHIBASHI, M
    TAKAKU, F
    NAKAOKA, H
    IMATAKA, K
    KITAHARA, Y
    FUJII, J
    LANCET, 1986, 2 (8503): : 402 - 403
  • [28] ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN
    BURNETT, JC
    KAO, PC
    HU, DC
    HESER, DW
    HEUBLEIN, D
    GRANGER, JP
    OPGENORTH, TJ
    REEDER, GS
    SCIENCE, 1986, 231 (4742) : 1145 - 1147
  • [29] ATRIAL-NATRIURETIC-PEPTIDE LEVELS IN TREATED CONGESTIVE-HEART-FAILURE
    KATOH, Y
    KUROSAWA, T
    TAKEDA, S
    KUROKAWA, S
    SAKAMOTOM, H
    MARUMO, F
    KIKAWADA, R
    LANCET, 1986, 1 (8485): : 851 - 851
  • [30] HEMODYNAMIC AND RENAL EFFECTS OF FENOLDOPAM IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND IMPAIRED RENAL-FUNCTION
    RUSSELL, DC
    JARMUKLI, NF
    LUI, CY
    WOODSON, D
    FALKENBERG, N
    CLINICAL RESEARCH, 1992, 40 (02): : A404 - A404